Cutler Group’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-330
| Closed | -$13K | – | 2081 |
|
2023
Q2 | $13K | Sell |
330
-3
| -0.9% | -$118 | ﹤0.01% | 932 |
|
2023
Q1 | $13K | Sell |
333
-897
| -73% | -$35K | ﹤0.01% | 954 |
|
2022
Q4 | $50K | Buy |
1,230
+370
| +43% | +$15K | ﹤0.01% | 820 |
|
2022
Q3 | $34K | Sell |
860
-140
| -14% | -$5.54K | ﹤0.01% | 1021 |
|
2022
Q2 | $42K | Buy |
1,000
+480
| +92% | +$20.2K | ﹤0.01% | 936 |
|
2022
Q1 | $23K | Buy |
520
+100
| +24% | +$4.42K | ﹤0.01% | 1320 |
|
2021
Q4 | $19K | Sell |
420
-80
| -16% | -$3.62K | ﹤0.01% | 1496 |
|
2021
Q3 | $23K | Sell |
500
-200
| -29% | -$9.2K | ﹤0.01% | 1491 |
|
2021
Q2 | $36K | Buy |
700
+100
| +17% | +$5.14K | ﹤0.01% | 1352 |
|
2021
Q1 | $30K | Hold |
600
| – | – | ﹤0.01% | 1338 |
|
2020
Q4 | $31K | Hold |
600
| – | – | ﹤0.01% | 1145 |
|
2020
Q3 | $26K | Sell |
600
-200
| -25% | -$8.67K | ﹤0.01% | 1084 |
|
2020
Q2 | $34K | Buy |
800
+700
| +700% | +$29.8K | ﹤0.01% | 968 |
|
2020
Q1 | $3K | Sell |
100
-100
| -50% | -$3K | ﹤0.01% | 1277 |
|
2019
Q4 | $9K | Hold |
200
| – | – | ﹤0.01% | 1250 |
|
2019
Q3 | $7K | Buy |
+200
| New | +$7K | ﹤0.01% | 1245 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 2287 |
|
2019
Q1 | – | Sell |
-100
| Closed | -$3K | – | 2286 |
|
2018
Q4 | $3K | Sell |
100
-100
| -50% | -$3K | ﹤0.01% | 1440 |
|
2018
Q3 | $9K | Buy |
+200
| New | +$9K | ﹤0.01% | 1309 |
|
2018
Q2 | – | Sell |
-100
| Closed | -$4K | – | 2352 |
|
2018
Q1 | $4K | Sell |
100
-700
| -88% | -$28K | ﹤0.01% | 1598 |
|
2017
Q4 | $34K | Buy |
800
+500
| +167% | +$21.3K | ﹤0.01% | 1231 |
|
2017
Q3 | $12K | Buy |
+300
| New | +$12K | ﹤0.01% | 1844 |
|
2017
Q2 | – | Sell |
-521
| Closed | -$21K | – | 3386 |
|
2017
Q1 | $21K | Sell |
521
-1,479
| -74% | -$59.6K | ﹤0.01% | 1860 |
|
2016
Q4 | $78K | Sell |
2,000
-4,100
| -67% | -$160K | ﹤0.01% | 1298 |
|
2016
Q3 | $269K | Buy |
6,100
+2,300
| +61% | +$101K | 0.01% | 641 |
|
2016
Q2 | $158K | Buy |
3,800
+2,300
| +153% | +$95.6K | 0.01% | 795 |
|
2016
Q1 | $60K | Buy |
+1,500
| New | +$60K | ﹤0.01% | 1207 |
|
2015
Q4 | – | Hold |
0
| – | – | – | 3341 |
|